Study Summary
This trial will study whether blood transfusions can help improve symptoms and quality of life for hospice patients.
Eligible Conditions
- Blood Cancers
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: 6 months
6 months
Proportion of subjects with improved palliative efficacy after receiving transfusions.
Proportion of subjects with improved quality of life after receiving transfusions.
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Tranfusions and blood collection
1 of 1
Experimental Treatment
20 Total Participants · 1 Treatment Group
Primary Treatment: Blood and/or platelet transfusion · No Placebo Group · N/A
Tranfusions and blood collectionExperimental Group · 2 Interventions: Blood and/or platelet transfusion, Complete blood count (CBC) collection · Intervention Types: Procedure, Procedure
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months
Who is running the clinical trial?
University of OklahomaLead Sponsor
421 Previous Clinical Trials
97,086 Total Patients Enrolled
Jennifer Holter, MDPrincipal InvestigatorUniversity of Oklahoma
2 Previous Clinical Trials
73 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments